Nanobiotix S.A.
NBTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001760854
No open-market purchases or sales by Nanobiotix S.A. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $218.4M in total; no superinvestor holds it.
Other share classesNNBXF
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +4 vs. previous quarter
- 19
- 13F valueReported value at the end of Q2 2026
- $218.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NBTX, Q2 2026
No superinvestor reported holding NBTX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Nanobiotix S.A. insiders from Form 4, newest first.
No open-market purchases or sales by Nanobiotix S.A. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Nanobiotix S.A. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Johnson & Johnson | 5,623,816 | $212.0M | 26.55% | 00.0% | Unchanged |
| Morgan Stanley | 49,789 | $1.88M | 0.00% | +13,515+37.3% | Added |
| Jane Street Group, LLC | 32,180 | $1.21M | 0.00% | +32,180 | New |
| HRT Financial LP | 27,332 | $1.03M | 0.00% | +27,332 | New |
| XTX Topco Ltd | 15,855 | $597.7K | 0.01% | +15,855 | New |
| Optiver Holding B.V. | 13,631 | $513.9K | 0.01% | +130+1.0% | Added |
| Marshall Wace, LLP | 10,044 | $378.7K | 0.00% | +805+8.7% | Added |
| Citadel Advisors LLC | 6,042 | $227.8K | 0.00% | +6,042 | New |
| BNP Paribas Arbitrage, SA | 4,044 | $152.5K | 0.00% | +485+13.6% | Added |
| UBS Group AG | 2,577 | $97.2K | 0.00% | −2,980−53.6% | Reduced |